Dose proportionality of fluticasone propionate from hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs
- 1 June 2000
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 94, S10-S16
- https://doi.org/10.1016/s0954-6111(00)80144-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthmaRespiratory Medicine, 2000
- Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthmaRespiratory Medicine, 2000
- Efficacy of inhaled corticosteroids in asthmaJournal of Allergy and Clinical Immunology, 1998
- Cumulative Dose-Response Study of Non-CFC Propellant HFA 134a Salbutamol Sulfate Metered-Dose Inhaler in Patients With AsthmaChest, 1996
- Assessment of Dose Proportionality: Report from the Statisticians in the Pharmaceutical Industry/Pharmacokinetics UK Joint Working PartyDrug Information Journal, 1995
- GR106642X: a new, non-ozone depleting propellant for inhalersBMJ, 1995
- The Continued Need for Metered Dose InhalersJournal of Aerosol Medicine, 1995
- Metered-dose inhalers and CFCs: what respiratory physicians need to knowRespiratory Medicine, 1994
- Structure-activity relationships of topically active steroids: the selection of fluticasone propionateRespiratory Medicine, 1990
- Control of Asthma by AerosolsNew England Journal of Medicine, 1986